4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-17-061354
EVP, QA & Regulatory Affairs sold 8,444 shares at $18.87 ($159,376)
- EVP, QA & Regulatory Affairs acquired 8,444 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2017-10-05 | Option exercise | +8,444 | $11.33 | $95,671 | 42,792 | D |
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2017-10-05 | Sale | −8,444 | $18.87 | $159,376 | 34,348 | D |
| Derivatives | |||||||
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2017-10-05 | Option exercise · Employee Stock Option (right to buy) | −8,444 | 25,330 | D | ||
| Open-market sales · 8,444 sh · avg $18.87 · $159,376 | |||||||
Loading xslF345X03/a4.xml…